Follow
Michael Ogundele
Michael Ogundele
Verified email at binghamton.edu
Title
Cited by
Cited by
Year
Disease-specific and glucocorticoid-responsive serum biomarkers for Duchenne Muscular Dystrophy
Y Hathout, C Liang, M Ogundele, G Xu, SM Tawalbeh, UJ Dang, ...
Scientific Reports 9 (1), 1-13, 2019
422019
Transdermal drug delivery: Microneedles, their fabrication and current trends in delivery methods
M Ogundele, HK Okafor
J. Pharm. Res. Int 18 (5), 1-14, 2017
292017
Validation of Chemokine Biomarkers in Duchenne Muscular Dystrophy
M Ogundele, JS Zhang, MV Goswami, ML Barbieri, UJ Dang, JS Novak, ...
Life 11 (8), 827, 2021
102021
Tandem Mass Tag-Based Serum Proteome Profiling for Biomarker Discovery in Young Duchenne Muscular Dystrophy Boys
TD Alayi, SM Tawalbeh, M Ogundele, HR Smith, AM Samsel, ML Barbieri, ...
ACS omega 5 (41), 26504-26517, 2020
92020
Microneedles: A potent modern tool in enhancing transdermal drug delivery
O Mi, HK Okafor
Current Trends in Biomedical Engineering & Biosciences 10 (5), 557-576, 2017
72017
Blood Accessible Biomarkers in Duchenne Muscular Dystrophy
M Ogundele
State University of New York at Binghamton, 2022
2022
Proteome Profiling of Muscle Cells and Muscle Tissue Using Stable Isotope Labeling by Amino Acids
E Canessa, MV Goswami, AM Samsel, M Ogundele, SM Tawalbeh, ...
Omics Approaches to Understanding Muscle Biology, 155-169, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–7